ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
621	Centers for Disease Control and Prevention	Html	en	Test Your Knowledge: Sickle Cell Disease - CDC Features	September is Sickle Cell Disease (SCD) Awareness Month. How much do you know about SCD? Take a quiz to find out and learn about the Centers for Disease Control and Prevention’s (CDC’s) work.	CDC.gov Current Features 0.906892	specific topic 0.706916	CLICK HERE
5833	Centers for Disease Control and Prevention	Html	en	Vinyl toluene - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
9036	Centers for Disease Control and Prevention	Html	en	Use of 13-Valent Pneumococcal Conjugate Vaccine and23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged6-18 Years with Immunocompromising Conditions: Recommendations ofthe Advisory Committee on Immunization Practices ACIP	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	pneumococcal conjugate vaccines 0.535337 functional asplenia 0.469692 13-valent pneumococcal conjugate 0.574333 Bacterial Core surveillance 0.546887 Pediatr Infect Dis 0.488527 vaccine efficacy 0.471814 average annual incidence 0.489811 sickle cell disease 0.578487 children 0.726539 heptavalent pneumococcal conjugate 0.480922 advisory committee 0.581414 Immunocompromised Persons 0.475295 off-label ACIP recommendation 0.482177 cochlear implants 0.537225 pneumococcal conjugate vaccine 0.920523 Active Bacterial Core 0.550557 National Center 0.481168 9-valent pneumococcal conjugate 0.527395 7-valent pneumococcal conjugate 0.575492 HIV-infected children 0.53365 pediatric immunocompromised population 0.471646 single PCV13 dose 0.523468 human immunodeficiency virus 0.494051 Respiratory Diseases 0.477641	pneumococcal polysaccharide vaccine 0.626646 CSF leaks 0.507246 7-valent conjugate vaccine 0.50901 human immunodeficiency 0.500889 United States 0.548414 immunocompromising conditions 0.666171 23-valent pneumococcal polysaccharide 0.557367 invasive pneumococcal disease 0.508162 polysaccharide vaccine series 0.474202 HIV-infected adults 0.512677 Immunization Practices 0.506042 ACIP 0.499721 PCV7-type IPD 0.51791 Immunocompromised Children Aged 0.536676 immunocompromised children 0.546916 PPSV23 dose 0.514875 unpublished data 0.513626 adverse events 0.500846 PCV13-type IPD 0.510142 acip recommendations 0.477525 common adverse events 0.485135 immunodeficiency virus-infected children 0.476837 et al 0.55396 IPD 0.577145	CLICK HERE
9115	Centers for Disease Control and Prevention	Html	en	Updated Recommendations for Use of VariZIG - United States,2013	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	investigational VariZIG 0.471713 varicella-zoster antibodies 0.484839 zoster immune globulin 0.985169 CDC 0.552424 anti–varicella-zoster virus antibodies 0.636061 United States 0.709311 hospital care 0.482718 VariZIG Recommendations 0.477859 high levels 0.484256 severe varicella 0.652174 initial exposure 0.485143 human immune globulins 0.491501 initial VariZIG administration 0.514786 immune globulin products 0.531379 neonatal period 0.481968 varicella vaccine 0.643472 premature infants 0.545128 ACIP work group 0.492729 VariZIG 0.745812 herpes zoster 0.572094 susceptible immunocompromised children 0.500008 expert opinion 0.477855 varicella zoster 0.822512 patient groups 0.604152	patients 0.476845 immunocompromised children 0.512021 IND protocol 0.478866 immune globulins 0.537549 varicella incidence 0.578211 varicella complications 0.572399 investigational new drug 0.481479 varicella 0.926009 postnatally acquired varicella 0.607907 high anti–varicella-zoster virus 0.491303 clinical varicella 0.652671 postexposure prophylaxis 0.487966 varicella-zoster virus 0.891342 entire period 0.479394 commercial varicella zoster 0.65435 exposure 0.665782 high risk 0.559179 cdc recommendations 0.533704 immune globulin preparation 0.7232 varizig administration 0.666998 varicella-zoster virus exposure 0.592069 household exposure 0.509973 volunteer blood donors 0.474575	CLICK HERE
9340	Centers for Disease Control and Prevention	Html	es	Utilización de modelos de clase latente para evaluar factores de conductas de riesgo y calidad de vida relacionada con la salud	null	Rhode Island 0.94606 Salud Pública 0.644069 alto riesgo 0.654902	Zack MM 0.684261 Chronic Dis 0.6725	CLICK HERE
12595	Centers for Disease Control and Prevention	Video	en	REACH- Community Diabetes Education -- Medical University of South Carolina	Hear how a community diabetes education class in South Carolina is changing lives and perceptions about diabetes. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://streaming.cdc.gov/vod2.php?id=f0cff7f2d78cd8b6c4b5672a252d99f120130308104252594	Medical University 0.433763 Education 0.215127	South Carolina 0.426381	CLICK HERE
13246	Centers for Disease Control and Prevention	Html	en	CDC Community Health Improvement Navigator | CDC Features	Invest in Your Community: Improve Health and Well-Being for All	stakeholders expert-vetted tools 0.402206 IRS Final Rule 0.544794 Service Final Rule 0.35147 online CHI Navigator 0.477816 community stakeholders 0.405849 Health Needs Assessments 0.72902 Collaborative CHI section 0.418676 collaborative CHI process 0.370967 targeted tools 0.240755 Disease Control 0.241905 brief vignettes highlight 0.355698 health behaviors 0.301336 health systems 0.618767 high-priority actions 0.245559 population health 0.296303 greater impact 0.357925 Asked Questions section 0.359929 economic vitality 0.243892 Excise Tax Return 0.319892 community health 0.916758 adequate nutrition—and 0.228738 relevant quotations 0.230905 public health agencies 0.632349 Community Health Needs 0.720483	community health systems 0.451256 collaborative CHI work 0.414127 Charitable Hospitals 0.573209 Key target audiences 0.33202 fact sheets 0.234992 patient outcomes 0.228389 action areas 0.359102 Interventions section 0.277073 potential partners 0.237492 health departments 0.304765 health care 0.588331 community organizations 0.281314 community partners 0.282665 clinical care 0.232919 Review information 0.234377 CHI Efforts section 0.410008 CHI process 0.438213 CHI Navigator 0.93956 collaborative chi 0.449364 community health assessment 0.466575 health care sector 0.417083 sustainable financial model 0.328748 greatest impact 0.237523 Community health improvement 0.516138	CLICK HERE
13934	Centers for Disease Control and Prevention	Html	en	Current Vaccine Shortages and Delays | CDC	Current Vaccine Shortages and Delays	production problems 0.376702 vaccine distribution 0.574776 Merck’s supply 0.427256 unexpected increased demand 0.47345 vaccine supplies 0.599949 regulatory issues 0.375384 scientific leaders 0.381766 Merck Vaccines 0.480193 Hepatitis A vaccine 0.960465 ongoing outbreaks 0.391532 adult immunization schedules 0.49425 Mumps Virus Vaccine 0.620029 sufficient supplies 0.384184 domestic supply 0.392472 private vaccine orders 0.641499 public health officials 0.456261 vaccine market 0.545033 Virus Vaccine Live 0.780489 pediatric Hepatitis 0.682638 vial versus syringe 0.454412 vaccine supply 0.713619 summary information 0.375781 United States shortages 0.535593 Measles Virus Vaccine 0.620936 time periods 0.378813	temporary changes 0.436205 adult Hepatitis 0.831416 largest group 0.380712 shortages page 0.47443 professional societies 0.378656 Rubella Virus Vaccine 0.620564 best use supplies 0.384913 Hepatitis B vaccine 0.735793 current supply constraints 0.466877 CDC staff 0.387879 unexpected demand 0.494477 web page 0.401677 specific presentation 0.380866 US-licensed manufacturers 0.461519 routine vaccination 0.395313 science-based decision 0.378635 childhood immunization schedule 0.58508 vaccine shortages 0.708306 appropriate individuals 0.378406 dialysis formulation 0.38314 Email Updates 0.374128 insufficient stockpiles 0.387004 Biological Product Shortages 0.523148 latest national information 0.474408	CLICK HERE
14235	Centers for Disease Control and Prevention	Html	null	Para mujeres embarazadas | El virus del Zika | CDC	Preguntas y respuestas, información para viajes...			CLICK HERE
14350	Centers for Disease Control and Prevention	Html	null	Zika and Guillain-Barré Syndrome | Zika virus	null			CLICK HERE